An observational study in Ultrasound, Machine Learning and Intraoperative Hypotension, sponsored by Shanghai 6th People's Hospital. Not yet recruiting at 2 sites in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-27.
Sponsored by Shanghai 6th People's Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 59 studies in Hypotension with a site in China — 26 open to participants now, 29 under way, none of them phase 3. Hypotension · China.
Among the 59 studies in Hypotension with a site in China, this one is the 9th largest by planned enrollment of the 19 observational ones that give a count, is one of 11 that started in 2026, is one of 19 observational ones, reaches primary completion later than 26 of the 28 other live ones, and was the 42nd registered.
892 studies on the registry are indexed under Hypotension; 199 are open to participants now.
Browse Hypotension studies →26 of the 59 studies in Hypotension with a site in China are open now. Recruiting first, the newest first:
Beijing Tsinghua Chang Gung Hospital · Sites in China
Ages 18–85
Peking Union Medical College Hospital · Sites in China
Ages 65+
Peking Union Medical College Hospital · Sites in China
Ages 65+
Sixth Affiliated Hospital, Sun Yat-sen University · Sites in China
Ages 65+
Nanfang Hospital, Southern Medical University · Sites in China
Ages 65–90
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 114 Hypotension studies recruiting now, 53 (46%) set no upper age limit and 36 (32%) stop at 75 or younger; 7 take children under 18; 16 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
59 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 2 · Phase 3 5 · Phase 4 9
First in 2013; this study’s year is marked. 11 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 440 is above the median of 93 across 269 observational studies indexed under Hypotension.
Median enrollment 129 across the 40 interventional studies, 200 across the 19 observational. Of the 20 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 59 has an industry lead sponsor. The 10 most frequent:
Shanghai 6th People's Hospital is the lead sponsor of 70 studies on the registry; 39 are open to participants now.
Shanghai 6th People's Hospital has 1 study filed under Hypotension — fewer than ten, so there is no comparison to draw.
11 of the studies in Hypotension with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07328958Sixth Affiliated Hospital, Sun Yat-sen UniversityEffect of Titrated Administration of Ciprofol on Perioperative Hypotension in Elderly Patients Undergoing Laparoscopic Abdominal Surgery: A Randomized Controlled Trial | 2026-12-30 |
| NCT07663695General Hospital of Ningxia Medical UniversityPropofol vs. Ciprofol for Anesthesia Induction in Frail Elderly Patients | 2026-12-31 |
| NCT07156474Lanyue ZhuImpact of Intraoperative Blood Pressure Components on Postoperative AKI: A Phenotype-Stratified Analysis | 2026-12-31 |
| NCT07239492Xuanwu Hospital, BeijingEfficacy and Safety Evaluation of Non-invasive Temporal Interference Stimulation for Blood Pressure Regulation | 2027-01-01 |
| NCT07949825The Fourth Affiliated Hospital of Zhejiang University School of MedicineEffect of Carotid Corrected Flow Time Guided Fluid Management on Post-Induction Hypotension in Elderly Patients | 2027-01-01 |
Add all 11 to your calendar (.ics) → With an account.
Among the 59 studies in Hypotension with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this observational study is to learn about intraoperative hemodynamic phenotypes in adult patients undergoing elective surgery under general anesthesia, using a new wearable ultrasound patch (CADFlow) that continuously monitors carotid and jugular blood flow. The main question it aims to answer is:
Can a machine learning model built solely on non-invasive carotid and jugular Doppler data accurately identify and classify a patient's hemodynamic phenotype in real time during surgery? Participants undergoing routine elective surgery who are monitored with the CADFlow device as part of standard care will be recorded continuously from after tracheal intubation until the end of surgery. The collected signals will be used to discover distinct hemodynamic phenotypes and to train a model that classifies each patient's phenotype in real time.
Accurate and continuous assessment of intraoperative hemodynamic status is fundamental to perioperative safety. Marked intraoperative hemodynamic instability is closely associated with postoperative complications and mortality, making precise hemodynamic management a central goal of perioperative medicine. Since the 1970s, hemodynamic profiling has relied primarily on parameters obtained from the pulmonary artery catheter (PAC); the four-quadrant framework built on pulmonary artery occlusion pressure (PAOP) and cardiac index (CI) - such as the Forrester-Diamond classification - distinguishes "warm-dry", "warm-wet", "cold-dry" and "cold-wet" phenotypes and remains a classic element of critical-care teaching. However, PAC placement is an invasive procedure carrying risks such as pulmonary-artery rupture and arrhythmias, which limits its routine use in surgical patients.
Machine learning (ML) has increasingly been explored for hemodynamic phenotype classification, and unsupervised methods have shown particular promise. Geri et al. identified five cardiovascular phenotypes in septic shock by combining clinical and echocardiographic data; Guinot et al. identified three congestion-related phenotypes in ICU patients using clinical, biomarker and Doppler data; and Kouz et al. and Jian et al. identified endotypes of intraoperative hypotension in surgical cohorts using hierarchical clustering and autoencoder-based deep clustering, respectively. Nevertheless, these studies share common limitations: most depend on invasive arterial or PAC-derived parameters; they capture arterial-side flow information only and lack venous indices needed to assess preload and right-heart function; and the complexity of ML "black-box" models raises the need to benchmark them against simpler, more cost-effective approaches.
CADFlow is a novel wireless, wearable Doppler-ultrasound patch that continuously and noninvasively monitors carotid artery and jugular vein hemodynamic parameters simultaneously. Its fully noninvasive design (a probe applied to the neck) avoids the risks of arterial puncture or PAC insertion, eliminates operator-dependent variability, and provides both carotid parameters (VTI, ccFT, peak systolic velocity Vs, dP/dt) and jugular parameters (Jvti, mean jugular flow jTAV, jugular pulsatility index jPI, jugular filling index JVI). This dual arterial-and-venous information is not available from arterial-only Doppler or invasive monitoring, and the resulting multimodal feature set is expected to improve the resolution, physiological interpretability and performance of unsupervised phenotype classification.
This study aims to apply CADFlow multimodal data and unsupervised learning to automatically discover intraoperative hemodynamic phenotypes and, on this basis, to develop a real-time phenotype classification model, thereby providing new tools and evidence for intelligent perioperative hemodynamic management
The criteria were revised on the registry on Oct 27, 2026. See what changed
Adult patients scheduled for elective, supine, general-anaesthesia surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adult patients aged 18 years or older scheduled for elective, supine, tracheal-intubation general-anaesthesia surgery will be enrolled into a single observational cohort.
Real-time phenotype classification performance of the machine-learning model
Using the phenotype labels derived from unsupervised clustering of intraoperative CADFlow multimodal data, a supervised learning model will be trained to classify the current intraoperative hemodynamic phenotype in real time. Performance will be assessed by accuracy, macro-averaged AUC and macro-averaged F1-score.
Time frame: Intraoperatively, from completion of tracheal intubation to the end of surgery
Phenotype feature-profile characterisation
Distribution of CADFlow parameters across the discovered phenotypes (box/ violin plots) to verify physiological interpretability
Time frame: Intraoperative
Stability and interpretability of the unsupervised clustering solution
Stability and interpretability of the unsupervised clustering solution (Silhouette coefficient, Calinski-Harabasz index, Bootstrap stability) and the association between phenotypes and intraoperative events such as hypotension and vasopressor use.
Time frame: Intraoperative
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Dec 2027, 13 months later.
Of 149 non-industry observational studies under Hypotension, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 25. This study's planned 13 months is close to that.
Counting every sponsor, half of 154 studies reached it within 11 months; a quarter within 5 and three quarters within 25.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 27, 2026: start Oct 2025 → Nov 2026, primary completion Jul 2027 → Dec 2027 and completion Aug 2027 → Jun 2028.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai 6th People's Hospital